Bioceros' Acquisition

Bioceros was acquired by Epirus Biopharmaceuticals on September 09, 2015.

Bioceros is a provider of services related to the preclinical development of monoclonal antibodies and generation of GMP-ready protein.…

Articles about Bioceros' Acquisition: